Predict your next investment

Vet-Stem company logo
HEALTHCARE | Biotechnology
vetstem.com

See what CB Insights has to offer

Founded Year

2002

Stage

Unattributed - III | Alive

Total Raised

$3.19M

Last Raised

$1.59M | 2 yrs ago

About Vet-Stem

Vet-Stem offers regenerative stem cell therapy for injured animals.

Vet-Stem Headquarter Location

12860 Danielson Court Suite B

Poway, California, 92064,

United States

858-748-2004

Latest Vet-Stem News

Canine Arthritis Treatment Market is Expected to Witness Rapid Growth by 2029 | Elanco, Zoetis, Bayer, VetStem Biopharma among Others

Jul 5, 2021

| Elanco, Zoetis, Bayer, VetStem Biopharma among Others A recent market study published by Future Market Insights (FMI) on the canine arthritis treatment including global industry analysis 2014-2018 & opportunity assessment 2019-2029, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the canine arthritis treatment, the growth prospects of the market are obtained with maximum precision. Canine Arthritis Treatment: Segmentation The global canine arthritis treatment is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. Treatment Report Chapters Chapter 01 – Executive Summary The report initiates with the executive summary of the canine arthritis treatment, which includes a summary of key findings and statistics of the market. It also includes market size and revenue distribution of market segment of the canine arthritis treatment. Chapter 02 – Market Overview Readers can find the definition and a detailed segmentation of the canine arthritis treatment in this chapter, which will help them understand the basic information about the canine arthritis treatment. Chapter 03 – Market Background This chapter explains the key macroeconomic factors, drivers, restraints, trends and opportunity analysis that are expected to influence the growth of the canine arthritis treatment over the forecast period. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section. Chapter 04 – Market Context This section includes premium insights such as regulatory scenario, disease epidemiology, industry view point and market evolution. This section helps readers understand the key factors associated with the canine arthritis treatment market. Chapter 05 – Global Canine Arthritis Treatment Value Analysis 2014-2018 & Opportunity Assessment 2019-2029 This section explains the global market value analysis and forecast for the Canine Arthritis treatment between the forecast periods of 2019-2029. This chapter includes a detailed analysis of the historical canine arthritis treatment market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029). Chapter 06 – Global Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Treatment Based on treatment type, the canine arthritis treatment market is segmented into Non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell therapy. In this chapter, readers can find information about the key trends and developments in the canine arthritis treatment and market attractiveness analysis based on treatment. Chapter 07 – Global Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Route of Administration This chapter provides details about the canine arthritis treatment based on mode of administration, and has been classified into oral and injectable. In this chapter, readers can understand the market attractiveness analysis based on route of administration. Chapter 08 – Global Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Distribution Channel This chapter provides details about the canine arthritis treatment market based on distribution channel, and has been classified into veterinary hospitals and clinics, retail pharmacies, drug stores, and E-Commerce. In this chapter, readers can understand the market attractiveness analysis based on distribution channel. Chapter 09 – Global Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Region This chapter explains how the canine arthritis treatment market will grow across various geographic regions such as North America, Latin America, Europe, Asia-Pacific excluding Japan, Japan, and Middle East & Africa (MEA). Chapter 10 – North America Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029 This chapter includes a detailed analysis of the growth of the North America canine arthritis treatment market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the pricing analysis, regional trends, and market growth based on the application and countries in North America. Chapter 11 – Latin America Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029 This chapter provides the growth scenario of the canine arthritis treatment market in Latin American countries such as Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided. Chapter 12 – Europe Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029 Important growth prospects of the canine arthritis treatment market based on its Distribution Channels in several countries such as Germany, the U.K., France, Spain, Italy, Russia, and the Rest of Europe are included in this chapter. Chapter 13 – Asia Pacific Excluding Japan Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029 This chapter highlights the growth of the canine arthritis treatment in Asia pacific excluding Japan by focusing on China, India, Australia & New Zealand, ASEAN and rest of APEJ. This section also help readers understand the key factors that are responsible for the growth of the canine arthritis treatment market in the APEJ region. Chapter 14 – Japan Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029 This chapter highlights the growth of the canine arthritis treatment in Japan. This section also help readers understand the key factors that are responsible for the growth of the canine arthritis treatment market in Japan. Request for Report Ask A Question @ https://www.futuremarketinsights.com/ask-question/rep-gb-3552 Chapter 15 – MEA Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029 This chapter provides information about how the canine arthritis treatment market will grow in major countries in the MEA region such as GCC Countries, South Africa, and the Rest of MEA, during the forecast period of 2019-2029. Chapter 16 – Competition Analysis In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the canine arthritis treatment market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Elanco, Zoetis, Bayer, VetStem Biopharma and among others. Chapter 17 – Assumptions and Acronyms This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the canine arthritis treatment report. Chapter 18 – Research Methodology This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about The Canine Arthritis Treatment. Explore Wide-ranging Coverage of FMI’s HealthcareLandscape Mammalian Transient Protein Expression Market  –The mammalian transient protein expression market has reflected steady growthon the back of growing demand from the biomedicine sector. Efforts into vaccinedevelopment continue to create possibilities for new opportunities. In Vitro Fertilization Banking Services Market  –According to the Centers for Disease Control and Prevention (CDC), about 10% ofwomen in the United States between ages 15 to 44 years have infertility whilethe rate of male infertility is 4.5-6% in North America. Cryopreservation for In-vitro Fertilization (IVF) Market  –According to analysis by Future Market Insights (FMI), cryopreservationfor IVF market surpassed a valuation of US$ 339 million in 2019. Themarket is set to reflect an impressive 10.2% CAGR through 2030. About FMI        Future Market Insights (FMI) is a leading provider of marketintelligence and consulting services, serving clients in over 150countries. FMI  isheadquartered in Dubai, the global financial capital, and has delivery centersin the U.S. and India. FMI’s latest  marketresearch reports  and industry analysis help businesses navigatechallenges and make critical decisions with confidence and clarity amidst breakneckcompetition. Our customized and syndicated market research reports deliveractionable insights that drive sustainable growth. A team of expert-ledanalysts at FMI continuously tracks emerging trends and events in a broad rangeof industries to ensure that our clients prepare for the evolving needs oftheir consumers. ContactUs

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Vet-Stem

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Vet-Stem is included in 2 Expert Collections, including Regenerative Medicine.

R

Regenerative Medicine

1,767 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Vet-Stem Patents

Vet-Stem has filed 4 patents.

The 3 most popular patent topics include:

  • Biotechnology
  • Cell biology
  • Developmental biology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/27/2020

9/28/2021

Transcription factors, Stem cells, Biotechnology, Cell biology, Developmental biology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

4/27/2020

00/00/0000

00/00/0000

00/00/0000

Grant Date

9/28/2021

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Transcription factors, Stem cells, Biotechnology, Cell biology, Developmental biology

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Vet-Stem Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Vet-Stem Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.